xAnts

RFK jr: Drug developers pressing ahead with public listings despite concerns over health role

Pharmaceutical and health stocks have gyrated in the days since Donald Trump nominated Robert Kennedy as secretary of the US Department of Health and Human Services. Photo / Tom Brenner, The Washington Post Two drug developers are pressing ahead with Read more